THERIVA BIOLOGICS INC COM NEW - Stock (SYN)

CUSIP: 87164U201

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Stock
Total 13F shares
11,773,907
Share change
+660,244
Total reported value
$2,511,000
Price per share
$0.21
Number of holders
22
Value change
+$79,322
Number of buys
8
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q2 2022

As of 30 Jun 2022, THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,773,907 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., TRUIST FINANCIAL CORP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, BLAIR WILLIAM & CO/IL, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.